PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.98%
R&D growth while TRAW reduces spending. John Neff would investigate strategic advantage.
58.15%
G&A growth while TRAW reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.40%
Operating expenses growth while TRAW reduces costs. John Neff would investigate differences.
20.40%
Total costs growth while TRAW reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
2.78%
D&A growth less than half of TRAW's 100.00%. David Dodd would verify if efficiency is sustainable.
-20.82%
EBITDA decline while TRAW shows 14.54% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-20.40%
Operating income decline while TRAW shows 14.51% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
97.30%
Other expenses growth 50-75% of TRAW's 158.93%. Bruce Berkowitz would examine cost efficiency.
-19.78%
Pre-tax income decline while TRAW shows 15.61% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.78%
Net income decline while TRAW shows 15.61% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
12.20%
EPS growth 50-75% of TRAW's 20.00%. Martin Whitman would scrutinize operations.
12.20%
Diluted EPS growth 50-75% of TRAW's 20.00%. Martin Whitman would scrutinize operations.
35.62%
Share count reduction below 50% of TRAW's 6.68%. Michael Burry would check for concerns.
35.62%
Diluted share reduction below 50% of TRAW's 6.68%. Michael Burry would check for concerns.